Could an HPV shot for babies help stop cervical cancer?
NCT ID NCT07377656
Summary
This study aims to see if an HPV vaccine is safe and produces a good immune response in very young children. It will test the vaccine in healthy infants, toddlers, and children aged 9 months to 5 years in Ghana, comparing their results to those of young women aged 15-20. The goal is to gather early evidence for potentially including HPV vaccination in routine childhood immunization schedules to prevent future cervical cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV VACCINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dodowa Health Research Center
Accra, Ghana
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.